BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35062808)

  • 21. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
    Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
    AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
    Bower M; Palmieri C; Dhillon T
    Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
    Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
    HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
    J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer in women living with HIV.
    D'Andrea F; Ceccarelli M; Facciolà A; Nunnari G; Pellicanò GF; Venanzi Rullo E
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1158-1164. PubMed ID: 30779085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
    Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
    AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Less cancer--or more--with HAART? Or, reflections on a late opus.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS cancers: conundrums and controversies.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):10-30. PubMed ID: 11364711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of patients living with HIV and cancer in Cali, Colombia.
    Parra-Lara LG; Arango-Ibañez JP; Martínez-Arboleda JJ; Bravo JC; Zambrano ÁR; Collazos P; Andino F; Badillo A; Estrada S; Rosso F
    Colomb Med (Cali); 2023; 54(3):e2015558. PubMed ID: 38098512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
    Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
    AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term cancer risk among people diagnosed with AIDS during childhood.
    Simard EP; Shiels MS; Bhatia K; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancies in HIV-Infected and AIDS Patients.
    Ji Y; Lu H
    Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
    Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
    J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer burden in women with HIV on Medicaid: A nationwide analysis.
    Zhou G; Koroukian SM; Navale SM; Schiltz NK; Kim U; Rose J; Cooper GS; Moore SE; Mintz LJ; Avery AK; Mukherjee S; Markt SC
    Womens Health (Lond); 2023; 19():17455057231170061. PubMed ID: 37184054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
    Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
    Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
    Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
    J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.